Cat. No. | Product name | CAS No. |
DCC5659 |
Zolantidine Dimaleate
Potent, selective, and brain penetrating H2 receptor antagonist |
104076-39-3 |
DCC5660 |
Zoledronate Disodium
Inhibitor of osteoclastogenesis and macrophage recruitment, decreasing bone turnover and stabilizing the bone matrix, exhibiting diverse anti-tumor effects in osteosarcoma |
131654-46-1 |
DCC5661 |
Zolimidine
Gastroprotective agent for the treatment of peptic ulcer |
1222-57-7 |
DCC5662 |
Zp1-12cl
Novel zinc sensor with a chloroalkane linker, reacting specifically with the engineered protein HaloTag, binding zinc ions with a threefold fluorescence enhancement |
|
DCC5663 |
Ztb23(r)
The first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor |
306324-21-0 |
DCC5664 |
Ztz240
Novel potentiator of KCNQ2 potassium channels |
325457-98-5 |
DCC5665 |
Zu-4280011
Novel COX-2 inhibitor |
1001770-63-3 |
DCC5666 |
Zuclopenthixol Dihydrochloride
Antagonist of D1 and D2 dopamine receptors. |
58045-23-1 |
DCC5667 |
Z-wehd-fmk
Potent, cell-permeable and irreversible caspase-1/5 inhibitor |
210345-00-9 |
DCC5668 |
Zwittermicin A
Natural antibiotic, having diverse biological activities including broad-spectrum antibiosis against Bacteria and lower Eukarya, plant disease suppression, and enhancement of the insecticidal activity of Bacillus thuringiensis toxin against lepidopteran l |
155547-95-8 |
DCC5669 |
Zwm026
Novel multi-target inhibitor, harboring selectivity of inhibiting EGFR T790M sparing wild-type EGFR |
|
DCC5670 |
Zxh-1-161
Featured
Novel Selective Degrader of GSPT1 |
2407654-51-5 |
DCC5671 |
Zx-j-19j
Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
1352576-02-3 |
DCC5672 |
Zx-j-19l
Novel inhibitor of Cyclophilin J (CyPJ) PPIase, demonstrating remarkable inhibition of tumor cell growth, comparable to CsA but much stronger than 5-fluorouracil |
1346754-06-0 |
DCC5673 |
Zxx2-77
Cyclooxygenase-1 inhibitor |
304913-22-2 |
DCC5674 |
Zydpla1
Novel next generation orally active DPP-4 inhibitor to treat Type 2 Diabetes |
1263402-76-1 |
DCC5675 |
Zyj-25e
Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
1287261-04-4 |
DCC5676 |
Zyj-34c
Novel histone deacetylase inhibitor (HDACi) with potent oral antitumor activities |
1314556-93-8 |
DCC5677 |
Zyj-34v
Oral active histone deacetylase inhibitor with potent antitumor activity |
1450662-32-4 |
DCC5678 |
Zyz-803
Novel slow H2S-NO-releasing hybrid, attenuating cardiac dysfunction after heart failure |
2088043-51-8 |
DC73867 |
EN171
Featured
EN171 covalently targets both C38 and C96 on 14−3−3 to enhance 14−3−3 interactions with ERα, YAP, and TAZ, leading to impaired estrogen receptor and Hippo pathway transcriptional activity. |
2191110-79-7 |
DC73868 |
CNB-001
CNB-001 is a pyrazole derivative of curcumin with neuroprotective properties, inhibits extracellular Aβ toxicity in hippocampal neurons with EC50 of 400 nM. |
1019110-87-2 |